In a stable COPD population, aging is associated with a mild grade of systemic inflammation, endothelial dysfunction (elevated ET-1), increased prevalence of cardiovascular comorbidities, and limited exercise tolerance. The gene discussed is EDN1; the disease is endothelial dysfunction.